Barak Investment House Company Description

Barak Investment House Ltd provides pharmaceutical solutions for patients and physicians in Israel and internationally.

It offers pharma-grade smokeless cannabis products, such as oral tablets, orodispersible tablets, sublingual tablets, oral oils, sublingual drops, solution for inhalation, pastilles, topicals, suppositories, and cannabis extracts in ethanol under the NAXIVA – PANAXOL, NAXIVA-PANAXOL-ONKO, PANAXIR SENSE, PANAXIR, Axiban, Tikva, Ultra Health, and Salus brands.

The company was formerly known as Panaxia Labs Israel Ltd and changed its name to Barak Investment House Ltd in May 2024.

Barak Investment House Ltd was incorporated in 2005 and is based in Lod, Israel.

Barak Investment House Ltd

Country	Israel
Founded	2005
Industry	Pharmaceutical Preparations
Employees	10
CEO	David Segal

Contact Details

Address: Bat Sheva 1 Lod, 7120101 Israel
Phone	972 7 2274 4144
Website	panaxia.co.il

Stock Details

Ticker Symbol	BARI
Exchange	Tel Aviv Stock Exchange
Fiscal Year	January - December
Reporting Currency	ILS
SIC Code	2834

Key Executives

Name	Position
David Segal	Chief Executive Officer
Yehuda Price	Chief Financial Officer